247 related articles for article (PubMed ID: 31723131)
1. eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma.
Chan K; Robert F; Oertlin C; Kapeller-Libermann D; Avizonis D; Gutierrez J; Handly-Santana A; Doubrovin M; Park J; Schoepfer C; Da Silva B; Yao M; Gorton F; Shi J; Thomas CJ; Brown LE; Porco JA; Pollak M; Larsson O; Pelletier J; Chio IIC
Nat Commun; 2019 Nov; 10(1):5151. PubMed ID: 31723131
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
[TBL] [Abstract][Full Text] [Related]
3. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.
Singh K; Lin J; Lecomte N; Mohan P; Gokce A; Sanghvi VR; Jiang M; Grbovic-Huezo O; Burčul A; Stark SG; Romesser PB; Chang Q; Melchor JP; Beyer RK; Duggan M; Fukase Y; Yang G; Ouerfelli O; Viale A; de Stanchina E; Stamford AW; Meinke PT; Rätsch G; Leach SD; Ouyang Z; Wendel HG
Cancer Res; 2021 Apr; 81(8):2002-2014. PubMed ID: 33632898
[TBL] [Abstract][Full Text] [Related]
4. eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.
Müller D; Shin S; Goullet de Rugy T; Samain R; Baer R; Strehaiano M; Masvidal-Sanz L; Guillermet-Guibert J; Jean C; Tsukumo Y; Sonenberg N; Marion F; Guilbaud N; Hoffmann JS; Larsson O; Bousquet C; Pyronnet S; Martineau Y
JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31672935
[TBL] [Abstract][Full Text] [Related]
5. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.
Seifert L; Werba G; Tiwari S; Giao Ly NN; Alothman S; Alqunaibit D; Avanzi A; Barilla R; Daley D; Greco SH; Torres-Hernandez A; Pergamo M; Ochi A; Zambirinis CP; Pansari M; Rendon M; Tippens D; Hundeyin M; Mani VR; Hajdu C; Engle D; Miller G
Nature; 2016 Apr; 532(7598):245-9. PubMed ID: 27049944
[TBL] [Abstract][Full Text] [Related]
6. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
Chu J; Zhang W; Cencic R; Devine WG; Beglov D; Henkel T; Brown LE; Vajda S; Porco JA; Pelletier J
Cell Chem Biol; 2019 Nov; 26(11):1586-1593.e3. PubMed ID: 31519508
[TBL] [Abstract][Full Text] [Related]
7. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.
Raza F; Waldron JA; Quesne JL
Biochem Soc Trans; 2015 Dec; 43(6):1227-33. PubMed ID: 26614665
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.
Chu J; Galicia-Vázquez G; Cencic R; Mills JR; Katigbak A; Porco JA; Pelletier J
Cell Rep; 2016 Jun; 15(11):2340-7. PubMed ID: 27239032
[TBL] [Abstract][Full Text] [Related]
9. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.
von Figura G; Fukuda A; Roy N; Liku ME; Morris Iv JP; Kim GE; Russ HA; Firpo MA; Mulvihill SJ; Dawson DW; Ferrer J; Mueller WF; Busch A; Hertel KJ; Hebrok M
Nat Cell Biol; 2014 Mar; 16(3):255-67. PubMed ID: 24561622
[TBL] [Abstract][Full Text] [Related]
10. Targeting eIF4A using rocaglate CR‑1‑31B sensitizes gallbladder cancer cells to TRAIL‑mediated apoptosis through the translational downregulation of c‑FLIP.
Cao Y; He Y; Yang L; Luan Z
Oncol Rep; 2021 Jan; 45(1):230-238. PubMed ID: 33416145
[TBL] [Abstract][Full Text] [Related]
11. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.
Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Xu J; Yu X
Biochim Biophys Acta; 2016 Dec; 1866(2):177-188. PubMed ID: 27600832
[TBL] [Abstract][Full Text] [Related]
12. Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer.
Lee MS; Dennis C; Naqvi I; Dailey L; Lorzadeh A; Ye G; Zaytouni T; Adler A; Hitchcock DS; Lin L; Hoffman MT; Bhuiyan AM; Barth JL; Machacek ME; Mino-Kenudson M; Dougan SK; Jadhav U; Clish CB; Kalaany NY
Nature; 2023 Apr; 616(7956):339-347. PubMed ID: 36991126
[TBL] [Abstract][Full Text] [Related]
13. A mucus production programme promotes classical pancreatic ductal adenocarcinoma.
Tonelli C; Yordanov GN; Hao Y; Deschênes A; Hinds J; Belleau P; Klingbeil O; Brosnan E; Doshi A; Park Y; Hruban RH; Vakoc CR; Dobin A; Preall J; Tuveson DA
Gut; 2024 May; 73(6):941-954. PubMed ID: 38262672
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.
Kasloff SB; Pizzuto MS; Silic-Benussi M; Pavone S; Ciminale V; Capua I
J Virol; 2014 Aug; 88(16):9321-34. PubMed ID: 24899201
[TBL] [Abstract][Full Text] [Related]
15. Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma.
Baker LA; Tuveson DA
Methods Mol Biol; 2019; 1882():117-133. PubMed ID: 30378048
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for translational inhibition by the tumour suppressor Pdcd4.
Loh PG; Yang HS; Walsh MA; Wang Q; Wang X; Cheng Z; Liu D; Song H
EMBO J; 2009 Feb; 28(3):274-85. PubMed ID: 19153607
[TBL] [Abstract][Full Text] [Related]
17. Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1.
Tsai PY; Lee MS; Jadhav U; Naqvi I; Madha S; Adler A; Mistry M; Naumenko S; Lewis CA; Hitchcock DS; Roberts FR; DelNero P; Hank T; Honselmann KC; Morales Oyarvide V; Mino-Kenudson M; Clish CB; Shivdasani RA; Kalaany NY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653947
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
Topalovski M; Hagopian M; Wang M; Brekken RA
J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
[TBL] [Abstract][Full Text] [Related]
19. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
20. Targeting the eIF4A RNA helicase as an anti-neoplastic approach.
Chu J; Pelletier J
Biochim Biophys Acta; 2015 Jul; 1849(7):781-91. PubMed ID: 25234619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]